Glancy Prongay Drops Out Of Blood Drug Lead Counsel Race
Glancy Prongay & Murray withdrew its bid to serve as lead counsel in a proposed class action brought against an Israeli biotech company accused of misleading its investors, stating that after...To view the full article, register now.
Already a subscriber? Click here to view full article